You Are Browsing ‘Medical’ Category

Molina Healthcare, Inc. (NYSE:MOH) announced their most recent earnings for the fourth quarter and year end results. Total revenue came in at a strong $2.8 billion, a 64% rise form the same period last year. Revenues from premiums came is at a solid $2.6 billion, a 62% bump over the same period last year….

As the positive environment is already built-up around biosimilar drug companies, there would not have been any better time like this for Pfenex Inc (NYSEMKT:PFNX)…

The shares of micro-cap company, Anthera Pharmaceuticals Inc (NASDAQ:ANTH), heavily surged in the last trading session as the company reported progress…

Esperion Therapeutics Inc (NASDAQ:ESPR)’s study of ETC-1002 received a major boost after the FDA moved to end a partial restriction in the trial of the…

When Regulus Therapeutics Inc (NASDAQ:RGLS) claimed to have achieved top-line results for its single-shot hepatitis drug RG-101, investors reacted to its…

Pfizer Inc. (NYSE:PFE) has just started to fill its shopping cart with the recent $17 billion buyout of Hospira, Inc. (NYSE:HSP), driving the stock of…

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) soared as it reported success for its Hepatitis C drug. The company said that its ACH-3102, when used in…

Atossa Genetics Inc (NASDAQ:ATOS) entered into a National Distribution deal with Thermo Fisher Scientific for distribution of its FullCYTE Breast Aspirator…

The shares of thinly traded Stereotaxis Inc (NASDAQ:STXS) surged during the previous trading session while there was not significant development reported…

Cambrex Corporation (NYSE:CBM) released earnings and blew consensus estimates away and also added they are expanding were expanding their Iowa facilities….

SPYR banner1